dapagliflozin
astrazeneca
['dapagliflozin']
dapagliflozin shown to improve time to event (worsened hf) for patients with lvef&gt;40% (including the hfmref-specific subgroup) - with or without diabetes. dropped today in nejm from #esccongress. #cooperimres 
Internal Medicine Chief Resident at Cooper University Hospital and Project Manager for investigator initiated trials in cardiology for Jefferson Health